103 related articles for article (PubMed ID: 26090123)
1. Cytotoxicity of gemcitabine-loaded thermosensitive liposomes in pancreatic cancer cell lines.
Affram K; Udofot O; Agyare E
Integr Cancer Sci Ther; 2015; 2(2):133-142. PubMed ID: 26090123
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antitumor activity of gemcitabine loaded thermosensitive liposomal nanoparticles and mild hyperthermia in pancreatic cancer.
Affram K; Udofot O; Cat A; Agyare E
Int J Adv Res (Indore); 2015 Oct; 3(10):859-874. PubMed ID: 26677454
[TBL] [Abstract][Full Text] [Related]
3. Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging.
Affram K; Udofot O; Singh M; Krishnan S; Reams R; Rosenberg J; Agyare E
PLoS One; 2017; 12(9):e0185116. PubMed ID: 28934281
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells.
Affram KO; Smith T; Ofori E; Krishnan S; Underwood P; Trevino JG; Agyare E
J Drug Deliv Sci Technol; 2020 Feb; 55():. PubMed ID: 31903101
[TBL] [Abstract][Full Text] [Related]
5. Mild hyperthermia enhances transport of liposomal gemcitabine and improves in vivo therapeutic response.
Kirui DK; Celia C; Molinaro R; Bansal SS; Cosco D; Fresta M; Shen H; Ferrari M
Adv Healthc Mater; 2015 May; 4(7):1092-103. PubMed ID: 25721343
[TBL] [Abstract][Full Text] [Related]
6. Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling.
Wang B; Shen C; Li Y; Zhang T; Huang H; Ren J; Hu Z; Xu J; Xu B
Onco Targets Ther; 2019; 12():5751-5765. PubMed ID: 31410021
[No Abstract] [Full Text] [Related]
7. Glypican-1-targeted and gemcitabine-loaded liposomes enhance tumor-suppressing effect on pancreatic cancer.
Mu Y; Wang D; Bie L; Luo S; Mu X; Zhao Y
Aging (Albany NY); 2020 Oct; 12(19):19585-19596. PubMed ID: 33035197
[TBL] [Abstract][Full Text] [Related]
8. microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression.
Liu Z; Du R; Long J; Guo K; Ge C; Bi S; Xu Y
Chin J Cancer Res; 2015 Jun; 27(3):267-78. PubMed ID: 26157323
[TBL] [Abstract][Full Text] [Related]
9. Co-encapsulation of gemcitabine and tocotrienols in nanovesicles enhanced efficacy in pancreatic cancer.
Maniam G; Mai CW; Zulkefeli M; Fu JY
Nanomedicine (Lond); 2021 Feb; 16(5):373-389. PubMed ID: 33543651
[No Abstract] [Full Text] [Related]
10. Low-dose valproic acid with low-dose gemcitabine augments MHC class I-related chain A/B expression without inducing the release of soluble MHC class I-related chain A/B.
Miyashita T; Miki K; Kamigaki T; Makino I; Tajima H; Nakanuma S; Hayashi H; Takamura H; Fushida S; Ahmed AK; Harmon JW; Ohta T
Oncol Lett; 2017 Nov; 14(5):5918-5926. PubMed ID: 29113227
[TBL] [Abstract][Full Text] [Related]
11. Preparation, optimization and in vitro characterization of stearoyl-gemcitabine polymeric micelles: a comparison with its self-assembled nanoparticles.
Daman Z; Ostad S; Amini M; Gilani K
Int J Pharm; 2014 Jul; 468(1-2):142-51. PubMed ID: 24731731
[TBL] [Abstract][Full Text] [Related]
12. ROS-Sp1 axis is involved in thermochemotherapy-enhanced sensitivity of pancreatic cancer cells to gemcitabine.
Xi P; Ma X; Hu F; Li L; Liu H; Zhou J; Wu W
Cell Biol Int; 2023 Nov; 47(11):1825-1834. PubMed ID: 37545170
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer.
Ndemazie NB; Bulusu R; Zhu XY; Frimpong EK; Inkoom A; Okoro J; Ebesoh D; Rogers S; Han B; Agyare E
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901721
[TBL] [Abstract][Full Text] [Related]
14. Gemcitabine-loaded albumin nanospheres (GEM-ANPs) inhibit PANC-1 cells in vitro and in vivo.
Li J; Di Y; Jin C; Fu D; Yang F; Jiang Y; Yao L; Hao S; Wang X; Subedi S; Ni Q
Nanoscale Res Lett; 2013 Apr; 8(1):176. PubMed ID: 23594566
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of 5-fluorouracil-loaded pH-sensitive liposomal nanoparticles in colorectal cancer cell lines.
Udofot O; Affram K; Israel B; Agyare E
Integr Cancer Sci Ther; 2015; 2(5):245-252. PubMed ID: 26691592
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermia enhances the sensitivity of pancreatic cancer SW1990 cells to gemcitabine through ROS/JNK signaling.
Jin H; Zhao Y; Yang J; Zhang X; Ma S
Oncol Lett; 2018 Nov; 16(5):6742-6748. PubMed ID: 30405817
[TBL] [Abstract][Full Text] [Related]
17. Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death.
Nakamura M; Sugimoto H; Ogata T; Hiraoka K; Yoda H; Sang M; Sang M; Zhu Y; Yu M; Shimozato O; Ozaki T
Oncogenesis; 2016 Jun; 5(6):e233. PubMed ID: 27294865
[TBL] [Abstract][Full Text] [Related]
18. Mixed poly(vinyl pyrrolidone)-based drug-loaded nanomicelles shows enhanced efficacy against pancreatic cancer cell lines.
Veeren A; Bhaw-Luximon A; Mukhopadhyay D; Jhurry D
Eur J Pharm Sci; 2017 May; 102():250-260. PubMed ID: 28323118
[TBL] [Abstract][Full Text] [Related]
19. Protopine/Gemcitabine Combination Induces Cytotoxic or Cytoprotective Effects in Cell Type-Specific and Dose-Dependent Manner on Human Cancer and Normal Cells.
Garcia-Gil M; Turri B; Gabriele M; Pucci L; Agnarelli A; Lai M; Freer G; Pistello M; Vignali R; Batistoni R; Marracci S
Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33530428
[TBL] [Abstract][Full Text] [Related]
20. Triptolide enhances the sensitivity of pancreatic cancer PANC-1 cells to gemcitabine by inhibiting TLR4/NF-κB signaling.
Ma JX; Sun YL; Yu Y; Zhang J; Wu HY; Yu XF
Am J Transl Res; 2019; 11(6):3750-3760. PubMed ID: 31312385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
